Vincent Vultaggio SEC EDGAR Filings (CIK 0002018766)

SEC EDGAR filings, ownership reports, and insider transactions for Vincent Vultaggio.

Business address
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY, 10018
Top holdings (ownership)
ZNTL
Get insider transactions for this reporting owner
Vincent Vultaggio has filed 6 SEC EDGAR filings since 11 Apr 2024

Latest Filings

Recent SEC filings for Vincent Vultaggio including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 10 Feb 2026 06 Feb 2026 001-39263
4 Open 4 document View SEC filing for 4 FORM 4 04 Feb 2026 02 Feb 2026 001-39263
4 Open 4 document View SEC filing for 4 FORM 4 09 Jan 2026 08 Jan 2026 001-39263
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2025 03 Feb 2025 001-39263
4 Open 4 document View SEC filing for 4 FORM 4 04 Oct 2024 04 Oct 2024 001-39263
3 Open 3 document View SEC filing for 3 FORM 3 11 Apr 2024 05 Apr 2024 001-39263

About this filer

Vincent Vultaggio files with the SEC under CIK 0002018766. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages